Skip to main content
. 2024 Oct 29;10(22):e39934. doi: 10.1016/j.heliyon.2024.e39934

Table 1.

Clinical Characteristics of the subjects.

Parameters Healthy controls T2DM P value
n (male/female) 30(20/10) 30(18/12)
Age (year) 56.7 ± 10.1 57.0 ± 13.1 0.895
BMI (kg/m2) 25.9 ± 3.6 28.5 ± 4.7 0.287
HbA1c(%) 5.7 ± 0.8 7.3 ± 1.2 0.0024
FBG(mmol/L) 4.9 ± 0.5 8.3 ± 1.1 0.0024
PBG (mmol/L) 6.8 ± 0.6 12.4 ± 0.5 0.0024
Family history 4(13.3 %) 8(26.67 %) 0.36
Smoking 5(16.67 %) 7(23.33 %) 0.747
Alcohol 5(16.67 %) 9(30 %) 0.36
Physical activity 12(40 %) 10(33.33 %) 0.789
Scr (umol/L) 95.51 ± 0.4 96.35 ± 0.6 0.895
TG(mmol/l) 1.54 ± 0.3 1.59 ± 0.5 0.895
TC(mmol/l) 4.34 ± 0.2 4.39 ± 0.4 0.895
LDL-C(mmol/L) 2.83 ± 0.25 2.86 ± 0.34 0.895

Data are presented as mean ± standard deviation or as the numbers (%) of participants. Continuous variables are subjected to a t-test (normal distribution) or the Kruskal-Wallis rank sum test (nonnormal distribution) depending on the normality of the distribution, and P-values are shown after applying the FDR or Bonferroni multiple tests, respectively; categorical variables are subjected to the χ2 test. Abbreviations: BMI – body mass index; HbA1c – hemoglobin A1c; FBG – fasting blood glucose; PBG – postprandial blood glucose; Scr – serum creatinine; TG – triglyceride; TC – serum total cholesterol; LDL-C – low-density lipoprotein cholesterol; p – statistical significance.